Comment on "Baricitinib for the Treatment of Alopecia Areata in Adults: Real World Analysis of 36 Patients"

J Am Acad Dermatol. 2024 Apr 15:S0190-9622(24)00631-5. doi: 10.1016/j.jaad.2024.02.064. Online ahead of print.

Authors

Deesha Desai¹, Ambika Nohria², Jerry Shapiro², Kristen Lo Sicco²

Affiliations

¹ University of Pittsburgh School of Medicine, Pittsburgh, PA; The Ronald O. Perelman Department of Dermatology, NYU Grossman School of Medicine, New York, NY. Electronic address: deesha.desai@nyulangone.org.
² The Ronald O. Perelman Department of Dermatology, NYU Grossman School of Medicine, New York, NY.

PMID: 38631444
DOI: 10.1016/j.jaad.2024.02.064

No abstract available

Keywords: Alopecia areata; Janus kinase inhibitor; baricitinib; medication safety.

Publication types

Letter